• NCCN
    Guidelines®
    • End-User License Agreement
    • NCCN Guidelines for
      Treatment of Cancer by Site
      • Acute Lymphoblastic Leukemia (Adult and AYA) 
      • Acute Lymphoblastic Leukemia (Pediatric and AYA)
      • Acute Myeloid Leukemia
      • AIDS-Related Kaposi Sarcoma
      • Anal Carcinoma
      • B-Cell Lymphomas
      • Basal Cell Skin Cancer
      • Bladder Cancer
      • Bone Cancer
      • Breast Cancer
      • Central Nervous System Cancers
      • Cervical Cancer
      • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
      • Chronic Myeloid Leukemia
      • Colon Cancer
      • Dermatofibrosarcoma Protuberans
      • Esophageal and Esophagogastric Junction Cancers
      • Gastric Cancer
      • Gastrointestinal Stromal Tumors (GIST)
      • Gestational Trophoblastic Neoplasia
      • Hairy Cell Leukemia
      • Head and Neck Cancer
      • Hepatobiliary Cancers
      • Hodgkin Lymphoma (Adult and AYA)
      • Hodgkin Lymphoma (Pediatric and AYA)
      • Kidney Cancer
      • Malignant Pleural Mesothelioma
      • Melanoma: Cutaneous
      • Melanoma: Uveal
      • Merkel Cell Carcinoma
      • Multiple Myeloma
      • Myelodysplastic Syndromes
      • Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Fusion Genes
      • Myeloproliferative Neoplasms
      • Neuroendocrine and Adrenal Tumors
      • Non-Small Cell Lung Cancer
      • Occult Primary
      • Ovarian Cancer
      • Pancreatic Adenocarcinoma
      • Pediatric Aggressive Mature B-Cell Lymphomas
      • Penile Cancer
      • Primary Cutaneous Lymphomas   
      • Prostate Cancer
      • Rectal Cancer
      • Small Bowel Adenocarcinoma
      • Small Cell Lung Cancer
      • Soft Tissue Sarcoma
      • Squamous Cell Skin Cancer
      • Systemic Light Chain Amyloidosis
      • Systemic Mastocytosis
      • T-Cell Lymphomas
      • Testicular Cancer
      • Thymomas and Thymic Carcinomas
      • Thyroid Carcinoma
      • Uterine Neoplasms
      • Vulvar Cancer
      • Waldenströms Macroglobulinemia/Lymphoplasmacytic Lymphoma
    • NCCN Guidelines for Detection,
      Prevention, & Risk Reduction
      • Breast Cancer Risk Reduction
      • Breast Cancer Screening and Diagnosis
      • Cervical Cancer Screening
      • Colorectal Cancer Screening
      • Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic
      • Genetic/Familial High-Risk Assessment:
        Colorectal
      • Lung Cancer Screening
      • Prostate Cancer Early Detection
    • NCCN Guidelines for
      Supportive Care
      • Adult Cancer Pain
      • Antiemesis
      • Cancer-Associated Venous Thromboembolic Disease
      • Cancer-Related Fatigue
      • Distress Management
      • Hematopoietic Cell Transplantation
      • Hematopoietic Growth Factors
      • Management of Immunotherapy-Related Toxicities
      • Palliative Care
      • Prevention and Treatment of Cancer-
        Related Infections
      • Smoking Cessation
      • Survivorship
    • NCCN Guidelines for
      Specific Populations
      • Adolescent and Young Adult (AYA) Oncology
      • Cancer in People with HIV
      • Older Adult Oncology
    • NCCN Guidelines for Patients®
      • Acute Lymphoblastic Leukemia
      • Acute Lymphoblastic Leukemia (Pediatric)
      • Acute Myeloid Leukemia
      • Adolescents and Young Adults with Cancer
      • Bladder Cancer
      • Bone Cancer
      • Brain Cancer/Gliomas
      • Breast Cancer
        • Noninvasive Breast Cancer
        • Invasive Breast Cancer
        • Metastatic Breast Cancer
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
      • Colon Cancer
      • Distress
      • Esophageal Cancer
      • Follicular Lymphoma
      • Head and Neck Cancers
        • Oral Cancers
      • Hepatobiliary Cancers
      • Hodgkin Lymphoma
      • Kidney Cancer
      • Lung Cancer
        • Early and Locally Advanced Lung Cancer
        • Metastatic Lung Cancer
      • Lung Cancer Screening
      • Malignant Pleural Mesothelioma
      • Melanoma
      • Multiple Myeloma
      • Myelodysplastic Syndromes
      • Myeloproliferative Neoplasms
      • Nausea and Vomiting
        • Order FREE Print Copy! Use Code VoucherN&V
      • Neuroendocrine Tumors
      • Non-Hodgkin's Lymphomas
        • Chronic Lymphocytic Leukemia
        • Diffuse Large B-Cell Lymphoma
        • Follicular Lymphoma
        • Mantle Cell Lymphoma
        • Mycosis Fungoides 
        • Peripheral T-cell Lymphoma
      • Ovarian Cancer
      • Pancreatic Cancer
      • Primary Central Nervous System Lymphoma
      • Prostate Cancer
      • Rectal Cancer
      • Soft Tissue Sarcoma
      • Squamous Cell Skin Cancer
      • Stomach Cancer
      • Survivorship Series
        • Survivorship Care for Healthy Living
        • Survivorship Care for Cancer-Related Late and Long-Term Effects 
      • Thyroid Cancer
      • Uterine Cancer
      • Waldenström's Macroglobulinemia
    • NCCN Guidelines with NCCN Evidence Blocks™
    • NCCN Framework for Resource Stratification of NCCN Guidelines
      (NCCN Framework™)
      • International Review of NCCN Framework™
    • NCCN Harmonized Guidelines™
    • NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™)
      • Search the NCCN Imaging AUC™ - FREE ACCESS
      • NCCN Imaging AUC™ User Guide
      • Permissions Requests
      • End-User License Agreement
    • International Adaptations & Translations
    • NCCN Guidelines Panels - Meeting Schedule
    • Transparency: Process and Recommendations
    • Submission Request to the NCCN Guidelines Panels
    • NCCN Pocket Guidelines
    • NCCN Disclosure Policies &
      Potential Conflicts of Interest
    • Licensing and Permissions
    • Stay up-to-date with NCCN Flash Updates
    • NCCN Mobile Apps
    • spacer image
  • NCCN
    Compendia
    • End-User License Agreement
    • NCCN Compendium®
      • End-User License Agreement
      • Search the NCCN Compendium®
      • Subscribe to the NCCN Compendium
      • No Longer Recommended Uses
      • Licensing and Permissions
      • NCCN Recognition Program
    • NCCN Biomarkers Compendium®
      • End-User License Agreement
      • Search the NCCN Biomarkers Compendium®
      • Subscribe to the NCCN Biomarkers Compendium®
      • Licensing and Permissions
      • About the NCCN Biomarkers Compendium®
    • NCCN Radiation Therapy Compendium™
      • End-User License Agreement
      • Search the NCCN Radiation Therapy Compendium™
      • Subscribe to the NCCN Radiation Therapy Compendium™
      • NCCN Radiation Therapy Compendium™ User Guide
      • Licensing & Permissions
      • About the NCCN Radiation Therapy Compendium™
    • NCCN Imaging AUC Compendium™
    • Subscribe to the NCCN Compendia
    • Licensing and Permissions
    • spacer image
  • NCCN
    Templates®
    • End-User License Agreement
    • Browse by Cancer Type
    • Subscribe to the NCCN Templates
    • Review the NCCN Chemotherapy Order Templates (NCCN Templates®) User Guide
    • EHR Integration
    • Licensing and Permissions
    • NCCN Chemotherapy Order Templates Committee
    • NCCN Chemotherapy Order Templates Reviewer Acknowledgement
    • spacer image
  • Educational Events
    & Programs
    • Live Meetings
      • NCCN 2021 Virtual Congress™: Breast Cancer with Updates from the 2020 San Antonio Breast Cancer Symposium (SABCS)
      • NCCN 2021 Virtual Annual Conference
      • NCCN Nursing Program: Advancing Oncology Nursing™
      • NCCN 2021 Virtual Oncology Fellows Program: New Horizons in Quality Cancer Care™
      • NCCN Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical and Biotech Business
        • Recorded NCCN Academy - June 29, 2020
      • NCCN Virtual Annual Congress: Hematologic Malignancies™
      • NCCN Global Academy for Excellence & Leadership in Oncology™
      • NCCN Corporate Council
      • NCCN Global Corporate Council
      • NCCN State Oncology Society Forum
      • NCCN Employer Forum
      • NCCN 2020 Virtual Annual Conference
      • View All
    • Webinars
      • New NCCN Guidelines for Pediatric Cancers: A Webinar Series
        • Pediatric ALL, January 22
        • Pediatric Aggressive Mature B-Cell Lymphoma, February 3
        • Wilms Tumor, February 19
      • NCCN Pharmacy Updates™ Webinar Series
        • Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors, February 15
        • Pancreatic Adenocarcinoma, March 11
        • Metastatic Colorectal Cancer, April 6
      • Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care 
        • Ovarian Cancer, January 25
        • Lung Cancer, February 24
        • Multiple Myeloma, March 3
      • NCCN 2020 Virtual Annual Conference
    • Online Learning
      • NCCN Virtual Annual Congress: Hematologic Malignancies™
      • NCCN Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™
      • NCCN 2020 Virtual Annual Conference
    • NCCN Oncology Policy Program
      • Articles
        • Delivering Value for Patients Across the Oncology Ecosystem
        • Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care
        • The State of Cancer Care in America: Impact of State Policy on Access to High-Quality Cancer Care
        • Advocating for Equity in Cancer Care
        • Policy Challenges and Opportunities to Address Changing Paradigms in Cancer Care Delivery
        • Policy Strategies for the “New Normal” in Health care to Ensure Access to High Quality Cancer Care
      • Comment Letters
      • Summits
        • December 10, 2020
    • NCCN Calendar of Events
    • NCCN Continuing Education Snapshot
    • spacer image
  • Subscriptions
    & Products
    • NCCN Compendium
    • NCCN Biomarkers Compendium
    • NCCN Radiation Therapy Compendium™
    • NCCN Templates
    • NCCN Imaging AUC™ - FREE ACCESS
    • NCCN Flash Updates™
    • Combination Subscriptions
      • NCCN Compendia, NCCN Templates, and NCCN Flash Updates
      • NCCN Compendium, NCCN Templates, and NCCN Flash Updates
      • NCCN Compendium and NCCN Templates
      • NCCN Compendia
      • NCCN Templates with Site License
    • NCCN Trends™ Surveys & Data
    • NCCN Best Practices Insights
    • NCCN eBulletin Newsletter
      • NCCN eBulletin
      • NCCN eBulletin Member Institution Edition
      • NCCN eBulletin Global Edition
      • NCCN eBulletin Patient Advocacy Edition
    • NCCN Health Information Technology Licensees
    • JNCCN — Journal of the National Comprehensive Cancer Network
      • Editorial Calendars
      • Subscribe Now
      • FAQ
      • Advertise with JNCCN
      • JNCCN Task Force Supplements
      • JNCCN 360
    • Advertising Opportunities
    • Supporter Opportunities
    • NCCN Online Catalog
    • spacer image
  • Clinical & Business
    Resources
    • Members Only
    • NCCN Corporate Council
    • NCCN Global Corporate Council
    • NCCN Academy
    • NCCN Global Academy
    • NCCN Insights: Analytics, Research & Consulting
      • NCCN Trends™ Surveys & Data
      • NCCN Trends™ International Surveys
      • NCCN Flash Updates™
    • NCCN Resource Tool: REMS
    • NCCN Collaboration with the National Business Group on Health
    • NCCN Virtual Reimbursement Resource Room and Reimbursement App
    • NCCN Health Information Technology Licensees
    • NCCN Oncology Research Program (ORP)
    • Informed Consent Language Database
    • Points to Consider on the Best Practices for Biorepositories, Registries and Databases
    • NCCN Shared Resources
    • NCCN Content Policies
      • NCCN Firewall Policy
      • NCCN Embargo Policy
    • Support NCCN
    • spacer image
  • NCCN
    Global
    • What we do - Global Initiatives
      • Africa
      • Asia
      • Europe
      • Latin America
      • Middle East North Africa
    • International Adaptations & Translations
    • NCCN Framework for Resource Stratification of NCCN Guidelines
      (NCCN Framework™)
    • NCCN Harmonized Guidelines™
    • NCCN China Website
    • NCCN Global Corporate Council
    • NCCN eBulletin Global Edition
    • Global Events
    • NCCN Global Academy for Excellence & Leadership in Oncology™
    • NCCN Trends™ Global Surveys
    • Get Involved - Opportunities for Global Collaboration and Sponsorship
    • Global Program Supporters
    • Contact NCCN Global
    • spacer image
  • NCCN Oncology
    Research Program
    • ORP Recent News
    • ORP Scientific Publications
    • ORP for Industry
    • Investigator Steering Committee
    • ORP Testimonials
    • Clinical Trials at NCCN Member Institutions
    • Find ORP Funded Clinical Trials at NCCN Member Institutions
    • ORP Research Opportunities
    • Informed Consent Language Database
    • Points to Consider on the Best Practices for Biorepositories, Registries and Databases
    • NCCN Shared Resources
    • ORP Disclosure Policy
    • spacer image
  • Patient
    Resources